多模態成像市場規模、佔有率及成長分析(按技術、應用、最終用戶和地區分類)-2026-2033年產業預測
市場調查報告書
商品編碼
1907115

多模態成像市場規模、佔有率及成長分析(按技術、應用、最終用戶和地區分類)-2026-2033年產業預測

Multimodal Imaging Market Size, Share, and Growth Analysis, By Technology (PET/CT, PET/MR), By Application (Oncology, Cardiology), By End Use, By Region -Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2024 年,多模態成像市場規模將達到 43.3 億美元,到 2025 年將達到 45.7 億美元,到 2033 年將達到 70.7 億美元,預測期(2026-2033 年)的複合年成長率為 5.6%。

多模態成像市場預計將迎來顯著成長,這主要得益於成像技術的不斷進步,例如解析度、擷取速度和靈敏度的提升。這些創新提高了診斷準確性和治療方案的製定效率,從而擴大了市場潛力。投資最尖端科技的公司正在增強多模態成像能力,而研究機構則在探索其在包括腫瘤學和神經病學在內的各個領域的應用。人口老化導致老齡化相關疾病發生率上升,預計將增加對診斷工具的需求。此外,政府的支持措施、資金籌措計畫和優惠的報銷政策正在推動新型影像技術的研發和應用,鼓勵醫療機構提升診斷能力以滿足不斷變化的醫療需求,從而進一步推動市場擴張。

多模態成像市場促進因素

隨著預防性醫療在全球醫療保健環境中日益重要,多模態影像市場正經歷顯著成長,其目的在於在降低成本的同時改善治療效果。人們對疾病早期檢測的興趣日益濃厚,這在很大程度上得益於多功能成像技術全面的功能和解剖評估能力。這些先進的成像技術在早期發現癌症、神經系統疾病和心血管疾病等易感人群的嚴重健康問題方面發揮著至關重要的作用。此外,醫學研究的進步也進一步推動了早期診斷的趨勢,促進了疾病管理策略的改善和整體公共衛生水準的提升。

限制多模態診斷影像市場的因素

多模態成像市場面臨許多限制因素,主要源自於這些先進系統的安裝、校準和維護的複雜性。將多種成像模式整合到一個統一的系統中,需要高超的技能以及硬體和軟體組件之間的密切配合。醫院和診斷中心的醫護人員在培訓和日常維護方面可能面臨挑戰,這可能導致他們在資源有限的環境中不願意採用這些技術。此外,頻繁的維護和必要的升級所帶來的高昂營運成本,也進一步阻礙了這些資源受限環境下技術的廣泛應用。

多模態成像診斷市場趨勢

隨著多模態影像市場與遠端醫療和遠距離診斷解決方案的融合日益加深,該市場正經歷著重大變革時期。這一趨勢提升了將影像資料安全傳輸給專家進行分析的能力,從而實現了遠端及時診斷。隨著數位醫療技術的不斷發展,遠端醫療為快速醫療諮詢和更便捷地獲取先進影像技術提供了強大的框架,尤其惠及了偏遠地區醫療資源匱乏的人。這種整合不僅擴大了先進成像方式的應用範圍,還有助於改善患者預後,使多模態成像成為未來醫療保健格局的關鍵組成部分。

目錄

介紹

  • 調查目標
  • 定義
  • 市場覆蓋範圍

調查方法

  • 資訊收集
  • 二手和一手資訊來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

    前景
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場動態
    • 促進要素
    • 機會
    • 抑制因素
    • 任務
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 價值鏈分析
  • 供應鏈分析
  • 專利分析
  • 貿易分析
  • 技術分析
  • 案例研究分析
  • 定價分析

多模態成像市場(按技術分類)

  • PET/CT系統
  • SPECT/CT系統
  • PET/MR系統
  • OCT/FMT系統
  • 其他多模態成像系統

多模態成像市場按應用領域分類

  • 腫瘤學
  • 心臟病學
  • 眼科
  • 神經病學
  • 研究
  • 其他用途

多模態成像市場(按最終用戶分類)

  • 醫院
  • 診斷影像中心
  • 學術和研究機構
  • 其他最終用戶

多模態成像市場:按地區分類的市場規模:

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲(MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭格局

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市佔率(2025 年)

主要企業簡介

  • GE Healthcare
  • Koninklijke Philips NV
  • Canon Medical Systems Corporation
  • Siemens Healthineers
  • Zeiss Group
  • Bruker
  • Mediso Ltd.
  • Neusoft Corporation
  • Infraredx, Inc.(part of Nipro Corporation)
  • Topcon Corporation
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Heidelberg Engineering
  • Spectrum Dynamics Medical
  • Minfound Medical Systems Co., Ltd.
  • Kindsway Biotech
  • Sofie Biosciences, Inc.
  • Fujifilm Corporation.
簡介目錄
Product Code: SQMIG35A2167

Multimodal Imaging Market size was valued at USD 4.33 Billion in 2024 and is poised to grow from USD 4.57 Billion in 2025 to USD 7.07 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The multimodal imaging market is poised for significant growth, fueled by ongoing advancements in imaging technology that enhance resolution, acquisition speed, and sensitivity. These innovations improve diagnostic accuracy and treatment planning, thereby expanding market potential. Companies investing in cutting-edge technologies are enhancing multimodal imaging performance, while research institutions are exploring its applications in various fields, including cancer and neurology. As the aging population faces a higher incidence of age-related medical conditions, the demand for diagnostic tools is set to rise. Furthermore, supportive government initiatives, funding programs, and favorable reimbursement policies are facilitating the development and adoption of new imaging technologies, driving the market expansion as healthcare providers seek to improve diagnostic capabilities in response to evolving healthcare needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Multimodal Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Multimodal Imaging Market Segments Analysis

Global Multimodal Imaging Market is segmented by Technology, Application, End User, and region. Based on Technology, the market is segmented into PET/CT, PET/MR, SPECT/CT, OCT/FMT, and Other multimodal imaging. Based on Application, the market is segmented into Brain & Neurology, Cardiology, Oncology, Ophthalmology, Research Applications, and Other Applications. Based on End Use, the market is segmented into Hospitals, Diagnostic Imaging Centers, Research and Academic Institutes, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Multimodal Imaging Market

The Multimodal Imaging market is experiencing significant growth as the global healthcare landscape increasingly prioritizes preventive care to enhance outcomes while minimizing expenses. A heightened emphasis on early disease detection has emerged, largely driven by the capabilities of multimodal imaging, which enables comprehensive functional and anatomical evaluations. This advanced imaging technology plays a crucial role in the early identification of critical health issues such as cancer, neurological disorders, and cardiovascular diseases in vulnerable populations. Furthermore, this trend of early diagnosis is reinforced by advancements in medical research, fostering improved strategies for disease management and enhancing overall public health.

Restraints in the Multimodal Imaging Market

The multimodal imaging market faces significant restraints due primarily to the complexity involved in the installation, calibration, and maintenance of these advanced systems. The technical integration of multiple imaging modalities into a unified system demands a high level of skill and collaboration between hardware and software components. Healthcare personnel at hospitals and diagnostic centers may encounter challenges related to training and ongoing maintenance, which could result in resistance to adoption in environments with limited resources. Additionally, the substantial operating costs attributed to frequent maintenance and necessary upgrades present further barriers to widespread acceptance in such restricted settings.

Market Trends of the Multimodal Imaging Market

The multimodal imaging market is experiencing a significant shift as it increasingly integrates with telemedicine and remote diagnostic solutions. This trend enhances the ability to securely transmit image data to specialists for analysis, facilitating timely diagnoses from distant locations. As digital healthcare technologies evolve, telemedicine offers a robust framework for accelerated consultations and improved access to sophisticated imaging techniques, particularly benefiting underserved populations in rural and isolated regions. This convergence not only boosts the reach of advanced imaging modalities but also drives better patient outcomes, positioning multimodal imaging as a vital component of the future healthcare landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Value Chain Analysis
  • Supply Chain Analysis
  • Patent Analysis
  • Trade Analysis
  • Technology Analysis
  • Case Study Analysis
  • Pricing Analysis

Multimodal Imaging Market, By Technology

  • Market Overview
  • PET/CT Systems
  • SPECT/CT Systems
  • PET/MR Systems
  • OCT/FMT Systems
  • Other Multimodal Imaging Systems

Multimodal Imaging Market, By Application

  • Market Overview
  • Oncology
  • Cardiology
  • Ophthalmology
  • Brain & Neurology
  • Research
  • Other Applications

Multimodal Imaging Market, By End User

  • Market Overview
  • Hospitals
  • Diagnostic Imaging Centers
  • Academic & Research Institutes
  • Other End Users

Multimodal Imaging Market Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2025

Key Company Profiles

  • GE Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Canon Medical Systems Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zeiss Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mediso Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neusoft Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Infraredx, Inc. (part of Nipro Corporation)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Topcon Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shanghai United Imaging Healthcare Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Heidelberg Engineering
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Spectrum Dynamics Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Minfound Medical Systems Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kindsway Biotech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sofie Biosciences, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Corporation.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments